Literature summary for 3.4.14.5 extracted from

Yilmaz, Y.; Atug, O.; Yonal, O.; Duman, D.; Ozdogan, O.; Imeryuz, N.; Kalayci, C.
Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fatty liver disease (2009), Med. Sci. Monit., 15, HY1-HY5.

Search for more literature for 3.4.14.5

Application

Application	Comment	Organism
medicine	dipeptidyl peptidase IV inhibitors can reduce fat infiltration in the liver and thus be a potential treatment for non-alcoholic fatty liver disease	Homo sapiens

Inhibitors

Inhibitors	Comment	Organism	Structure
sitagliptin	trade name Januvia	Homo sapiens
vildagliptin	trade name Galvus	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	-	-	-

Synonyms

Synonyms	Comment	Organism
dipeptidyl peptidase IV	-	Homo sapiens
DPPIV	-	Homo sapiens

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)